Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Can anti-PGL-I antibody isotypes differentiate leprosy contacts and leprosy patients?

Albuquerque AA, Mateus C, Rodrigues R, et al. Pathogens and global health. 2022;
Publication

Erythema nodosum leprosum (type 2 reaction) in a patient with neurofibromatosis type 1.

George R, D'Souza S, Masoodi I. BMJ case reports. 2022;
Publication

Case of leprosy mimicking preseptal cellulitis: a diagnostic dilemma.

Sarkar D, Chawla H, Singh P, et al. BMJ case reports. 2022;
Publication

Transcriptomic Analysis of Stimulated Response in Peripheral Blood Mononuclear Cells Reveal Potential Biomarkers for Early Diagnosis of Leprosy.

Yuan Y, Liu J, You Y, et al. Frontiers in cellular and infection microbiology. 2021;
Download PDF
Publication

First cases of Mycobacterium leprae (Hansen’s disease) detection in Côte d’Ivoire using molecular diagnosis (PCR)

N’Golo David C, Christiane AA, Henry K, et al. Lepra. Leprosy Review. 2021; 92 (4) : 406-411.
Download PDF
Publication

Laboratory diagnosis of leprosy: Two staining methods from bacilloscopy and rapid ml flow test

Pedro HDSP, Ule Belotti N, Nardi SMT, et al. Medknow. International Journal of Mycobacteriology. 2021; 10 (4) : 393.
Download PDF
Publication

A simple assay to quantify mycobacterial lipid antigen-specific T cell receptors in human tissues and blood.

Zhou A, Scriba T, Day C, et al. PLoS neglected tropical diseases. 2021; 15 (12) : e0010018.
Download PDF
Publication

Development of immunodiagnostic tests for leprosy: from biomarker discovery to application in endemic areas

van Hooij A. Leiden University. Faculty of Medicine, Leiden University Medical Center. 2021;
Download PDF
Publication

Histopathological Correlation in Different Types of Leprosy in a Tertiary Health Care Centre

Ravali M, Thomas J. Sciencedomain International. Journal of Pharmaceutical Research International. 2021;
Download PDF
Publication

Quali-quantitative synthesis of the global scenario of patent families about leprosy.

Meneghin R. Ciencia & saude coletiva. 2021; 26 (11) : 5411-5426.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 80
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD